TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Unilabs Laboratoriemedisin AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
204,366
|
159,180
|
152,979 |
| Financial expenses |
2,566
|
2,365
|
2,961 |
| Earnings before taxes |
13,772
|
1,889
|
4,205 |
| Total assets |
132,117
|
109,499
|
113,991 |
| Current assets |
71,018
|
41,541
|
45,557 |
| Current liabilities |
54,799
|
41,285
|
41,897 |
| Equity capital |
48,437
|
37,430
|
35,861 |
| - share capital |
358
|
358
|
358 |
| Employees (average) |
88
|
86 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.7%
|
34.2%
|
31.5% |
| Turnover per employee |
2,322
|
1,851 | |
| Profit as a percentage of turnover |
6.7%
|
1.2%
|
2.7% |
| Return on assets (ROA) |
12.4%
|
3.9%
|
6.3% |
| Current ratio |
129.6%
|
100.6%
|
108.7% |
| Return on equity (ROE) |
28.4%
|
5.0%
|
11.7% |
| Change turnover |
45,186
|
6,201
|
-20,463 |
| Change turnover % |
28%
|
4%
|
-12% |
| Chg. No. of employees | 2 | ||
| Chg. No. of employees % | 2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.